# Neulasta

NDC: 55513-099
Generic name: pegfilgrastim
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260331

FDA application: BLA125031

## Active ingredients

- PEGFILGRASTIM: 4 mg/.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-099"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-099
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fdfe5d72-6b80-435a-afa4-c5d74dd852ce